The ERVW-1 gene helps make a protein called syncytin-1, which is mainly active in the placenta during pregnancy. This gene plays an important role in helping placental cells join together to build the outer layer that moves oxygen and nutrients from the pregnant parent to the developing baby. If the gene does not work properly, placental development may be less effective, which can contribute to pregnancy problems such as poor fetal growth or preeclampsia. The ERVW-1 gene also comes from an ancient viral sequence that became part of human DNA long ago.
What is a gene?
A gene is a stretch of DNA that carries instructions cells use to make molecules or regulate activities in the body. Some genes provide the instructions for proteins, which do much of the cell’s work. Others mainly guide when certain activities happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you react to food, stress, or medicines. More detail on this topic is available in the LearnHub.
Overview
ERVW-1Gene function
What if the gene works
The ERVW-1 gene helps cells in the placenta join together to form a layer that supports pregnancy. This layer helps move oxygen and nutrients from the pregnant person to the developing baby.
Risk
What if the gene does not work
Changes in the ERVW-1 gene can range from milder to more severe and may reduce or disrupt syncytin-1 activity, making it harder for placental cells to fuse and form the placenta’s outer working layer.
Treatment
What does that mean for your treatment
No treatment or management approach tied specifically to the ERVW-1 gene is currently established in clinical guidelines. The ERVW-1 gene is being studied as a biomarker and possible drug target in multiple sclerosis, pregnancy related conditions, and some cancers.
Gene function
What if the gene works
During pregnancy, the ERVW-1 gene helps build the placenta, the organ that connects a developing baby with the uterus. It makes a protein called syncytin-1 that allows certain placental cells to join together. This creates a smooth outer layer that supports the placenta’s normal work.
The ERVW-1 gene makes syncytin-1, a protein that helps placental cells fuse into one continuous layer. This joining step is a central part of normal placental development.
By helping cells merge, the ERVW-1 gene supports the placenta’s outer lining. This lining creates a broad surface where oxygen and nutrients can pass to the developing baby and waste can move back.
In simple terms, what the ERVW-1 gene does in pregnancy is help shape the placenta so it can do its routine work. This supports the day to day connection between the pregnant person and the developing baby.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help explain normal differences between people, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works to a greater degree and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ERVW-1 gene can change how much syncytin-1 is made, how stable it is, and how well it reaches the cell surface to merge neighboring cells. Milder variants may partly reduce this fusion activity, while more severe variants can disrupt key protein shapes, interfere with binding to cell surface partners, or create a shortened protein with little or no activity. This range shows how ERVW-1 gene variants affect gene function at the cellular level.
How variants are linked to conditions
The ERVW-1 gene does not yet have a broadly confirmed link to a specific inherited health condition, though research on how ERVW-1 variants are linked to conditions is still evolving. Some studies have suggested possible associations, but these findings have not reached broad clinical consensus. Anyone with a confirmed ERVW-1-related diagnosis should rely on guidance from their doctor or genetic counselor for personal interpretation.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are common across the general population. Most do not directly affect health and instead reflect the natural diversity seen in people. For many genes, carrying a variant connected with a condition indicates a possible association rather than a confirmed diagnosis, especially when multiple genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to ERVW-1. This gene has been studied in areas like pregnancy and immune-related conditions, but personal risk is not defined by ERVW-1 alone and can be shaped by many other genes and life factors.
Inheritance of ERVW-1 variants
There is not yet a broadly confirmed Mendelian pattern for how ERVW-1 gene variants are inherited in relation to a specific human condition. Current research does not support describing ERVW-1 gene inheritance as clearly autosomal dominant, autosomal recessive, or X linked for an established disease. The ERVW-1 gene sits on chromosome 7, which is an autosome, so you inherit one copy from each parent. In that basic sense, how ERVW-1 gene variants are inherited follows the usual pattern for genes on nonsex chromosomes.
What does my ERVW-1 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific health condition for ERVW-1. If you have a specific ERVW-1 result and want to understand what it could mean for your relatives, a doctor or genetic counselor can help put it in context for your family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the ERVW-1 gene usually uses DNA from blood, saliva, or a cheek swab, and the lab reads the gene sequence to look for changes. Results list any variants found and how well they are understood, often using categories such as benign, uncertain, likely pathogenic, or pathogenic.
When should I consider getting a genetic test?
There isn’t yet a broadly established, ERVW-1-specific clinical reason for genetic testing. Decisions about testing are best made with a doctor or genetic counselor, based on your symptoms, pregnancy history, and family history.
A genetic result is only one part of your health story
Genetic findings can provide valuable insight, but how much they reveal varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results may help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, cause more side effects in another, or seem less effective for someone else. Differences in how the body absorbs, breaks down, transports, or responds to a drug are common, and these differences can shape both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic variation can affect a person’s response to medicines. By studying links between genes and medications, it helps explain why the same treatment may not work the same way for everyone. With many drugs, genes can influence both how strong a medicine’s effects are and how the body handles it. This information can support treatment choices that are more informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the ERVW-1 gene
When should I seek medical advice?
There is not yet a broadly confirmed link between this gene and how people respond to medicines, so routine treatment decisions are not based on it. If you have side effects, questions about a medication, or any new health concerns, discuss them with your doctor.
History
The ERVW-1 gene entered medical history through research on human endogenous retroviruses, stretches of ancient viral DNA that became part of the human genome over evolutionary time. In the late 1990s, scientists identified its protein product, later named syncytin-1, as a striking example of viral genetic material being reused by human biology. Initially understood only through visible traits, later recognized as tied to a specific gene, this discovery helped shift thinking about so called “junk DNA” and showed that some inherited viral sequences have important roles. From these first observations, research expanded steadily. ERVW-1 became one of the best known examples of how old viral DNA can be woven into normal human development.